Table 2.
Type | No. of cases (%) | Recur or meta | DSS |
---|---|---|---|
SCC | 62 (71.2) | 15 | 82 |
ACC | 7 (8.2) | 1 | 100 |
MM | 4 (4.7) | 1 | 75 |
VC | 4 (4.7) | 0 | 100 |
Sar | 3 (3.5) | 1 | 66.6 |
MC | 2 (2.3) | 1 | 100 |
BCC | 1 (1.8) | 0 | 100 |
GCC | 1 (1.8) | 0 | 100 |
Total | 84 (100.0) | 18 | 83.1 |
SCC squamous cell carcinoma, ACC adenoid cystic carcinoma, MM malignant melanoma, VC verrucous carcinoma, Sar sarcoma, MC mucoepidernoid carcinoma, BCC basal cell carcinoma, GCC ghost cell carcinoma, Recur recurrence, meta metastasis, DSS disease specific 5-year survival rate)